A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer
暂无分享，去创建一个
W. Symmans | V. Valero | N. Ibrahim | G. Rauch | B. Adrada | E. Mittendorf | D. Tripathy | S. Moulder | R. Candelaria | L. Huo | J. Litton | M. Karuturi | S. Damodaran | R. Layman | D. Ramirez | R. Murthy | S. Prabhakaran | C. Yam | R. Sun | H. Garber | E. Ravenberg | A. Thompson | Qingqing Ding | A. Clayborn | J. White